The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

NeuroDerm Ltd. / See Company Profile

Acquisition / Mitsubishi Tanabe Pharma acquires NeuroDerm for $1bn / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Jul. 25, 2017

Financing / NeuroDerm nets $81mm in public offering / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 10, 2016

Financing / NeuroDerm nets $72.3mm in FOPO / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Jul. 21, 2015

CytRx Corp. / See Company Profile

Alliance / NantCell gets exclusive aldoxorubicin rights from CytRx / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 1, 2017

Financing / CytRx nets $14.1mm through public stock sale / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: May 1, 2017

Financing / CytRx nets $7.7mm through registered direct offering of common and preferred shares / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 20, 2016

Spark Therapeutics Inc. / See Company Profile

Financing / Spark Therapeutics nets $380mm in FOPO / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 4, 2017

Alliance / Pfizer helps Spark develop gene therapy for hemophilia / Strategic Transactions / Deal Date: Dec. 1, 2014 / Update Date: Jul. 1, 2017

Alliance / Spark licenses exclusive rights to Selecta's SVP platform for up to five targets / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Jan. 4, 2017


Medical Devices

Email Alert | RSS Feed

Osprey Medical Inc. / See Company Profile

Financing / Osprey Medical to raise $25.7mm in private placement / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 11, 2017

Financing / Medical device company Osprey Medical raises $A28mm in private placement / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Aug. 5, 2016

Financing / Osprey Medical raises $A16.3mm in private placement / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Apr. 9, 2015

NxStage Medical Inc. / See Company Profile

Acquisition / NxStage acquired by Fresenius for $2bn / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 8, 2017

Financing / NxStage Medical nets $73.3mm through FOPO / Strategic Transactions / Deal Date: Nov. 1, 2010 / Publish Date: Dec. 17, 2010

Alliance / NxStage Medical signs deal with Asahi Kasei Kuraray Medic / Strategic Transactions / Deal Date: Jun. 1, 2009 / Publish Date: Jun. 26, 2009

Intuitive Surgical Inc. / See Company Profile

Alliance / JustRight enters adult MIS market through deal with Intuitive Surgical / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 10, 2017

Alliance / Intuitive Surgical and Fosun invest $100mm in new robotic-assisted surgical device JV / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Sep. 30, 2016

Alliance / Intuitive Surgical gets IP from Cardica / Strategic Transactions / Deal Date: Aug. 1, 2010 / Update Date: Aug. 1, 2016


In Vitro Diagnostics

Email Alert | RSS Feed

CombiMatrix Corp. / See Company Profile

Acquisition / Invitae acquires public reproductive diagnostics company CombiMatrix for up to $33mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Financing / CombiMatrix raises $8mm in FOPO / Strategic Transactions / Deal Date: Mar. 1, 2016 / Publish Date: Mar. 22, 2016

Financing / CombiMatrix nets $11.2mm through public offering of preferred shares / Strategic Transactions / Deal Date: Dec. 1, 2013 / Publish Date: Jan. 8, 2014

Invitae Corp. / See Company Profile

Acquisition / Invitae acquires perinatal testing firm Good Start for $40mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Financing / Invitae sells $73.5mm of its common and preferred shares through private placement / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Acquisition / Invitae acquires public reproductive diagnostics company CombiMatrix for up to $33mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

ImmunArray Pvt. Ltd. / See Company Profile

Alliance / Kindstar gets rights to ImmunArray's lupus test in China / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 8, 2017

Financing / ImmunArray closes $10mm Series B round / Strategic Transactions / Deal Date: Jul. 1, 2016 / Publish Date: Aug. 29, 2016

Financing / Series A round brings $3mm to ImmunArray; $2.2mm added in additional closing / Strategic Transactions / Deal Date: Apr. 1, 2012 / Update Date: Apr. 1, 2013


Pharmaceuticals

Email Alert | RSS Feed

Melinta Therapeutics Inc. / See Company Profile

Acquisition / Anti-infectives firms Cempra, Melinta merge / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 11, 2017

Financing / Melinta enters financing agreement with Oberland Capital / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 30, 2017

Alliance / Eurofarma gets Brazilian rights to Melinta's delafloxacin / Strategic Transactions / Deal Date: Jan. 1, 2015 / Publish Date: Jun. 21, 2017

Aclaris Therapeutics Inc. / See Company Profile

Financing / Aclaris Therapeutics nets $70.5mm in FOPO / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 18, 2017

Acquisition / Aclaris buys Confluence Life Sciences for $20mm plus $80mm in earn-outs / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 9, 2017

Financing / Aclaris closes $$85.5mm FOPO / Strategic Transactions / Deal Date: Nov. 1, 2016 / Publish Date: Dec. 14, 2016

Loxo Oncology Inc. / See Company Profile

Alliance / Loxo acquires BTK inhibitor program from Redx Pharma / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 1, 2017

Financing / Public offering nets $245.8mm for Loxo Oncology / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jul. 5, 2017

Alliance / Ventana to create a companion diagnostic for Loxo's larotrectinib / Strategic Transactions / Deal Date: Mar. 1, 2017 / Publish Date: May 12, 2017

Biotechnology

Biotechnology

Email Alert | RSS Feed

NeuroDerm Ltd. / See Company Profile

Acquisition / Mitsubishi Tanabe Pharma acquires NeuroDerm for $1bn / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Jul. 25, 2017

Financing / NeuroDerm nets $81mm in public offering / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 10, 2016

Financing / NeuroDerm nets $72.3mm in FOPO / Strategic Transactions / Deal Date: Jul. 1, 2015 / Publish Date: Jul. 21, 2015

CytRx Corp. / See Company Profile

Alliance / NantCell gets exclusive aldoxorubicin rights from CytRx / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 1, 2017

Financing / CytRx nets $14.1mm through public stock sale / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: May 1, 2017

Financing / CytRx nets $7.7mm through registered direct offering of common and preferred shares / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 20, 2016

Spark Therapeutics Inc. / See Company Profile

Financing / Spark Therapeutics nets $380mm in FOPO / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 4, 2017

Alliance / Pfizer helps Spark develop gene therapy for hemophilia / Strategic Transactions / Deal Date: Dec. 1, 2014 / Update Date: Jul. 1, 2017

Alliance / Spark licenses exclusive rights to Selecta's SVP platform for up to five targets / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Jan. 4, 2017

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Osprey Medical Inc. / See Company Profile

Financing / Osprey Medical to raise $25.7mm in private placement / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 11, 2017

Financing / Medical device company Osprey Medical raises $A28mm in private placement / Strategic Transactions / Deal Date: Aug. 1, 2016 / Publish Date: Aug. 5, 2016

Financing / Osprey Medical raises $A16.3mm in private placement / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Apr. 9, 2015

NxStage Medical Inc. / See Company Profile

Acquisition / NxStage acquired by Fresenius for $2bn / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 8, 2017

Financing / NxStage Medical nets $73.3mm through FOPO / Strategic Transactions / Deal Date: Nov. 1, 2010 / Publish Date: Dec. 17, 2010

Alliance / NxStage Medical signs deal with Asahi Kasei Kuraray Medic / Strategic Transactions / Deal Date: Jun. 1, 2009 / Publish Date: Jun. 26, 2009

Intuitive Surgical Inc. / See Company Profile

Alliance / JustRight enters adult MIS market through deal with Intuitive Surgical / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 10, 2017

Alliance / Intuitive Surgical and Fosun invest $100mm in new robotic-assisted surgical device JV / Strategic Transactions / Deal Date: Sep. 1, 2016 / Publish Date: Sep. 30, 2016

Alliance / Intuitive Surgical gets IP from Cardica / Strategic Transactions / Deal Date: Aug. 1, 2010 / Update Date: Aug. 1, 2016

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

CombiMatrix Corp. / See Company Profile

Acquisition / Invitae acquires public reproductive diagnostics company CombiMatrix for up to $33mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Financing / CombiMatrix raises $8mm in FOPO / Strategic Transactions / Deal Date: Mar. 1, 2016 / Publish Date: Mar. 22, 2016

Financing / CombiMatrix nets $11.2mm through public offering of preferred shares / Strategic Transactions / Deal Date: Dec. 1, 2013 / Publish Date: Jan. 8, 2014

Invitae Corp. / See Company Profile

Acquisition / Invitae acquires perinatal testing firm Good Start for $40mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Financing / Invitae sells $73.5mm of its common and preferred shares through private placement / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

Acquisition / Invitae acquires public reproductive diagnostics company CombiMatrix for up to $33mm / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 3, 2017

ImmunArray Pvt. Ltd. / See Company Profile

Alliance / Kindstar gets rights to ImmunArray's lupus test in China / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 8, 2017

Financing / ImmunArray closes $10mm Series B round / Strategic Transactions / Deal Date: Jul. 1, 2016 / Publish Date: Aug. 29, 2016

Financing / Series A round brings $3mm to ImmunArray; $2.2mm added in additional closing / Strategic Transactions / Deal Date: Apr. 1, 2012 / Update Date: Apr. 1, 2013

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Melinta Therapeutics Inc. / See Company Profile

Acquisition / Anti-infectives firms Cempra, Melinta merge / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 11, 2017

Financing / Melinta enters financing agreement with Oberland Capital / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jun. 30, 2017

Alliance / Eurofarma gets Brazilian rights to Melinta's delafloxacin / Strategic Transactions / Deal Date: Jan. 1, 2015 / Publish Date: Jun. 21, 2017

Aclaris Therapeutics Inc. / See Company Profile

Financing / Aclaris Therapeutics nets $70.5mm in FOPO / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 18, 2017

Acquisition / Aclaris buys Confluence Life Sciences for $20mm plus $80mm in earn-outs / Strategic Transactions / Deal Date: Aug. 1, 2017 / Publish Date: Aug. 9, 2017

Financing / Aclaris closes $$85.5mm FOPO / Strategic Transactions / Deal Date: Nov. 1, 2016 / Publish Date: Dec. 14, 2016

Loxo Oncology Inc. / See Company Profile

Alliance / Loxo acquires BTK inhibitor program from Redx Pharma / Strategic Transactions / Deal Date: Jul. 1, 2017 / Publish Date: Aug. 1, 2017

Financing / Public offering nets $245.8mm for Loxo Oncology / Strategic Transactions / Deal Date: Jun. 1, 2017 / Publish Date: Jul. 5, 2017

Alliance / Ventana to create a companion diagnostic for Loxo's larotrectinib / Strategic Transactions / Deal Date: Mar. 1, 2017 / Publish Date: May 12, 2017

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel